Subscribe to this column
Michael Paul Link, MD, FASCO
Michael P. Link, MD, FASCO, is the Lydia J. Lee Professor in Pediatric Oncology at Stanford University School of Medicine. He is an ASCO Past President and Chair-Elect of the Bylaws Committee. His research interests include the biology and management of non-Hodgkin lymphoma and Hodgkin disease in children and the treatment of bone and soft-tissue sarcomas.
Oct 10, 2011
I had written about abandonment of care among children in the developing world as a grave concern for oncologists everywhere because of its implications for our failure to deliver the...
Sep 26, 2011
A commentary in the August issue of The Lancet Oncology should serve as a disconcerting “reality check” for any pediatrician or oncologist. Although we now can cure 80% of children...
Jul 18, 2011
The international community of oncologists continues to gain importance in ASCO; one might suggest that ASCO’s name—the American Society of Clinical Oncology—does not adequately reflect its membership or its mission. ASCO is increasingly an international society with one-third of its more than 30,...
Jul 09, 2011
I just read the Personal History column in the June 13 & 20, 2011, New Yorker—“The Aquarium”— a powerful recounting by Aleksandar Hemon...
Jun 24, 2011
One of the responsibilities of the ASCO President and President-Elect at the Annual Meeting is to serve as spokespersons for the Society during interviews with the press about the exciting science presented in the course of the Meeting. This year, I participated in six or seven interview sessions....
May 24, 2011
In June, I will become the 47th president of ASCO. This is an intimidating prospect for anyone—ASCO is a complex organization representing multiple subspecialties from all over the world. The membership now exceeds 30,000 individuals from private practice, academia, research, industry, and advocacy...
- Page 2 of 2
- « first
- ‹ previous